NST-001

· NeuroSystec Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NST-001, covering 2013-04-22 to 2013-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus [Phase 1]